Clinical Trials List
2014-07-01 - 2028-12-30
Phase III
Terminated8
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- 王國鐘 Division of General Surgery
- 林燕淑 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 賴亦貞 Division of Radiology
- Jiun-I Lai Division of Radiation Therapy
- 邱仁輝 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 金光亮 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- Wei-Wu Chen 無
- YEN-SHEN LU Division of Hematology & Oncology
- 張允中 Division of Radiology
- 郭文宏 Division of General Surgery
- SUNG-HSIN KUO Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
- 楊雅雯 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- 張潤忠 Division of Radiology
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳佳哲 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林智一 Division of Others
- Liang-Chih Liu Division of General Surgery
- 蔡伯邦 Division of Radiology
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Fang-Ming Chen Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- Fu Ouyang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張宏泰 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
630 participants
